Virtu Financial’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

Virtu Financial’s Portfolio EFTR Stock Details EFTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-18,021	Closed	-$5K	–	2084
2024 Q2	$5K	Buy	+18,021	New	+$42.8K	﹤0.01%	1188
2023 Q3	–	Sell	-406	Closed	-$8K	–	2078
2023 Q2	$8K	Buy	+406	New	+$6.86K	﹤0.01%	1374
2022 Q3	–	Sell	-627	Closed	-$22K	–	2364
2022 Q2	$22K	Buy	+627	New	+$37.9K	﹤0.01%	1315
2021 Q4	–	Sell	-698	Closed	-$245K	–	2287
2021 Q3	$245K	Buy	+698	New	+$225K	0.02%	813

Other funds holding EFTR

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Virtu Financial's EFTR Position: Q3 2024 in Review

Virtu Financial sold out of eFFECTOR Therapeutics, Inc. Common Stock (EFTR) in Q3 2024, closing a stake of 18,021 shares — an estimated $5K sold.

Virtu Financial first reported a position in EFTR in Q3 2021 and held it in 4 quarters. The position peaked at $245K in Q3 2021. 3 funds tracked by Wall St. Rank hold EFTR as of Q3 2024.

Virtu Financial reported no remaining eFFECTOR Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Virtu Financial sold 18,021 eFFECTOR Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $5K.
Virtu Financial first reported a position in eFFECTOR Therapeutics, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
Virtu Financial's eFFECTOR Therapeutics, Inc. Common Stock position peaked at $245K in Q3 2021.
3 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Virtu Financial's 13F filing for Q3 2024, filed 20 Nov 2024.